Quantbot Technologies LP Purchases 28,872 Shares of Maximus, Inc. (NYSE:MMS)

Quantbot Technologies LP increased its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 228.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 41,500 shares of the health services provider's stock after buying an additional 28,872 shares during the period. Quantbot Technologies LP owned 0.07% of Maximus worth $3,098,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC boosted its position in shares of Maximus by 1.4% in the third quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock valued at $142,109,000 after acquiring an additional 21,532 shares during the period. Van Berkom & Associates Inc. increased its position in shares of Maximus by 8.5% in the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock worth $93,792,000 after purchasing an additional 98,264 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Maximus by 7.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after purchasing an additional 71,598 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Maximus by 2.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock worth $54,748,000 after buying an additional 16,772 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Maximus by 8.2% during the 4th quarter. Bank of New York Mellon Corp now owns 570,740 shares of the health services provider's stock valued at $42,606,000 after buying an additional 43,421 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Insider Activity

In related news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

MMS has been the topic of several research reports. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a research note on Thursday, January 2nd.

Maximus Trading Up 1.5 %

Maximus stock traded up $1.03 during trading hours on Thursday, reaching $68.06. The stock had a trading volume of 357,414 shares, compared to its average volume of 491,808. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The company has a fifty day simple moving average of $70.42 and a 200-day simple moving average of $78.09. The stock has a market cap of $3.85 billion, a PE ratio of 14.64 and a beta of 0.71. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.76%. Maximus's dividend payout ratio (DPR) is 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.